Barbara Bruno Fagundes Marques

Prof. Barbara Bruno Fagundes Marques

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in Oral Diseases
Verified
Journal Article
Open access
PDF file
BMBarbara Bruno Fagundes Marques
Barbara Bruno Fagundes Marques
TGTaísa Coelho Guimarães
Taísa Coelho Guimarães
RFRicardo Guimarães Fischer
Ricardo Guimarães Fischer
JTJustine Monteiro Monnerat Tinoco
Justine Monteiro Monnerat Tinoco
FPFábio Ramoa Pires
Fábio Ramoa Pires
ETEduardo Muniz Barretto Tinoco
Eduardo Muniz Barretto Tinoco
Objective The aim of the present case–control study was to evaluate the morphological aspects of the epithelial cells from the dorsum of the tongue and the expression of the SARS-CoV-2 Spike protein in these cells, in patients with and without COVID-19 infection. Methods 24 individuals with at least one symptom of COVID-19 were recruited among inpatients from Hospital Universitário Pedro Ernesto (Rio de Janeiro, Brazil). 14 patients who tested positive for COVID-19 by RT-PCR were included in the case group, and 10 patients who tested negative were included in the control group. Cytological smears from the dorsum of the tongue were obtained from all patients and analyzed using immunohistochemistry directed against SARS-CoV-2-Spike protein. Morphological changes in epithelial cells were analyzed using light microscopy. Results Immunohistochemistry showed that 71% of the COVID-19 patients presented epithelial cells positive for the presence of the SARS-CoV-2 Spike protein, and all cells coming from patients in the control group were negative. Cytological analysis showed significant differences when comparing epithelial cells from COVID-19-positive and COVID-19-negative patients. Conclusion COVID-19 may generate dimensional changes in tongue epithelial cells; however, further studies are necessary to understand how this happens.

11 February 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
Tatiana Kelly da Silva FidalgoTatiana Kelly da Silva Fidalgo
Tatiana Kelly da Silva Fidalgo
LFLiana Bastos Freitas-Fernandes
Liana Bastos Freitas-Fernandes
BMBarbara Bruno Fagundes Marques
Barbara Bruno Fagundes Marques
CACaroline Souza de Araújo
Caroline Souza de Araújo
BSBruno Jefferson da Silva
Bruno Jefferson da Silva
AVAna Paula Valente
Ana Paula Valente
The SARS-CoV-2 virus primarily infects salivary glands suggesting a change in the saliva metabolite profile; this shift may be used as a monitoring instrument during SARS-CoV-2 infection. The present study aims to determine the salivary metabolomic profile of patients with and post-SARS-CoV-19 infection. Patients were without (PCR−), with SARS-CoV-2 (PCR+), or post-SARS-CoV-2 infection. Unstimulated whole saliva was collected, and the 1H spectra were acquired in a 500 MHz Bruker nuclear magnetic resonance spectrometer at 25 °C. They were subjected to multivariate analysis using principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), as well as univariate analysis through t-tests (SPSS 20.0, IL, USA), with a significance level of p < 0.05. A distinction was found when comparing PCR− subjects to those with SARS-CoV-2 infection. When comparing the three groups, the PLS-DA cross-validation presented satisfactory accuracy (ACC = 0.69, R2 = 0.39, Q2 = 0.08). Seventeen metabolites were found in different proportions among the groups. The results suggested the downregulation of major amino acid levels, such as alanine, glutamine, histidine, leucine, lysine, phenylalanine, and proline in the PCR+ group compared to the PCR− ones. In addition, acetate, valerate, and capronic acid were higher in PCR− patients than in PCR+. Sucrose and butyrate were higher in post-SARS-CoV-2 infection compared to PCR−. In general, a reduction in amino acids was observed in subjects with and post-SARS-CoV-2 disease. The salivary metabolomic strategy NMR-based was able to differentiate between non-infected individuals and those with acute and post-SARS-CoV-19 infection.

28 December 2021 in Oral Diseases
Verified
Journal Article
Open access
PDF file
TGTaísa Coelho Guimarães
Taísa Coelho Guimarães
BMBarbara Bruno Fagundes Marques
Barbara Bruno Fagundes Marques
MCMarcelle Viana de Castro
Marcelle Viana de Castro
DSDaniele Angst Secco
Daniele Angst Secco
LPLuís Cristóvão Moraes Sobrino Porto
Luís Cristóvão Moraes Sobrino Porto
RFRicardo Guimarães Fischer
Ricardo Guimarães Fischer
Objective: To evaluate the reduction in the salivary viral load using oral antiseptic mouthwashes in patients testing positive for COVID‐19.Methods: Sixty‐three individuals were recruited after testing positive for COVID‐19 by real‐time RT‐PCR assay and divided into 5 groups. Group 1 received sterile water, group 2 received 1.5% hydrogen peroxide solution (HP), group 3 received 0.12% chlorhexidine (CHX), group 4 received 0.1% sodium hypochlorite solution (NaClO), and group 5 received sequential rinses using CHX and HP. After collecting the initial saliva sample, individuals were asked to use the designated mouthwash for 1 min. Additional saliva samples were collected immediately after rinsing, 15, and 30 min after rinsing. Real‐time RT‐PCR assays for RNA detection of SARS‐CoV‐2 were performed on the saliva samples.Results: There were no significant differences among the experimental groups and the control group in any period. Compared to the baseline values, there was a significant reduction in the number of copies of SARS‐CoV‐2 after 30 min in group 2 and immediately after the initial mouthwash in group 4.Conclusions: No experimental group demonstrated a significant reduction in the viral load compared to the control group.

29 April 2022 in Brazilian Dental Journal
Verified
Journal Article
Open access
TGTaísa Coelho Guimarães
Taísa Coelho Guimarães
BMBarbara Bruno Fagundes Marques
Barbara Bruno Fagundes Marques
JTJustine Monteiro Monnerat Tinoco
Justine Monteiro Monnerat Tinoco
LPLuis Cristóvão Porto
Luis Cristóvão Porto
ETEduardo Muniz Barretto Tinoco
Eduardo Muniz Barretto Tinoco
RFRicardo Guimarães Fischer
Ricardo Guimarães Fischer
The World Health Organization has declared the widespread spread of SARS-CoV-2 and its associated disease (COVID-19) a public health emergency. The standard gold test for detecting the virus is the RT-PCR, performed from nasopharyngeal swab (NPS) samples. However, this test may be uncomfortable for the patient and requires specific training and attire from the health professional responsible for collecting the sample. Therefore, the search for alternative ways to collect samples that may be used in the diagnosis of COVID-19 is relevant. This study aimed to compare the results obtained from NPS and saliva samples. NPS and saliva samples were collected from 189 symptomatic outpatients suspected of COVID-19, who came to Piquet Carneiro Polyclinic. RNA extraction was performed using the Bio-Gene DNA/RNA Viral Extraction kit (Bioclin®). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) reactions used the Molecular SARS-CoV-2 (E / RP) kit (Bio-Manguinhos). The results indicated that 142 showed a non-detectable result (ND), while 47 showed a detectable result (D). Among the 142 "ND", 137 (94.4%) saliva samples obtained the same result, while 5 samples (3.4%) were "D". Among the 47 "D" swab samples, 35 (74.4%) showed the same result in the saliva samples. The sensitivity of the saliva test was 0.74 and the specificity was 0.97. The positive predictive value was 0.88 while the negative predictive value was 0.92. The results showed that detection of Sars-CoV-2 using saliva samples showed high sensitivity and specificity compared to nasopharyngeal swabs.

31 December 2025 in Revista de Patologia do Tocantins
Verified
Journal Article
Open access
PDF file
BMBarbara Bruno Fagundes Marques
Barbara Bruno Fagundes Marques
GCGuilherme Goulart Cabral-Oliveira
Guilherme Goulart Cabral-Oliveira
BDBreno Pereira Menezes Domingos
Breno Pereira Menezes Domingos
FBFernanda Brito
Fernanda Brito
A Doença de Sjögren (SD) é uma desordem sistêmica crônica autoimune caracterizada por infiltração de linfócitos nas glândulas exócrinas, atingindo principalmente as glândulas lacrimais e salivares, sendo a xeroftalmia e a xerostomia os sintomas mais prevalentes. A xerostomia provoca mudanças na microbiota oral, podendo levar a quadros de disbiose e ao desenvolvimento de desordens orais. Este trabalho relata o caso clínico de uma paciente do sexo feminino, 38 anos, que procurou tratamento odontológico devido à insatisfação com a estética do sorriso. Durante a anamnese, relatou diagnóstico prévio de SD. Foi realizada sialometria estimulada para avaliar o fluxo salivar, com média de 0,1 ml/min de saliva produzida. Com o intuito de avaliar a alteração da microbiota dessa paciente ao longo do tratamento, uma amostra de saliva foi diluída e cultivada em placas contendo CHROMagar Candida, no início do tratamento e ao final dos tratamentos de adequação do meio bucal. Observou-se alteração das espécies prevalentes no início e ao final das intervenções odontológicas. Corroborando com dados que demonstram que tratamentos odontológicos para promoção e adequação do meio bucal em pacientes com SD, sem o uso de agentes antimicrobianos, podem provocar mudanças na microbiota oral desfazendo quadros disbióticos. PALAVRAS-CHAVE: Doença de Sjögren; Candida; Disbiose.